QSC Tirzepatide is a high-purity GLP-1 receptor agonist peptide with 99% purity, specifically designed for research applications. This pharmaceutical grade compound (CAS 2381089-83-2) is supplied in sterile vials with various concentration options to meet different research requirements.
As a dual GIP and GLP-1 receptor agonist, QSC Tirzepatide demonstrates superior stability and biological activity. The product undergoes rigorous quality control testing to ensure consistent purity and performance in research settings.
Our QSC Tirzepatide is particularly suitable for metabolic disorder research, with potential applications in diabetes and obesity studies. The peptide is provided in lyophilized form for optimal stability and reconstitution flexibility.
Key advantages of our QSC Tirzepatide include batch-to-batch consistency, reliable purity levels, and customized packaging options. Researchers can request specific concentrations and vial quantities to suit their experimental needs.